Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2003
03/20/2003US20030053959 Breathing a dry powder; antidiabetic agent
03/20/2003CA2472102A1 Calcium-influx inhibitory factor and method of isolation thereof
03/20/2003CA2460348A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
03/20/2003CA2460330A1 Method for the preparation of crystalline tetrahydrobenzothiepines
03/20/2003CA2460023A1 Method for treating coumarin-induced hemorrhage
03/20/2003CA2459973A1 Carbazole derivatives and their use as npy5 receptor antagonists
03/20/2003CA2459947A1 Compositions and methods for aa4rp assay
03/20/2003CA2459945A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003CA2459862A1 Oxyntomodulin for preventing or treating excess weight
03/20/2003CA2459760A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions
03/20/2003CA2459515A1 Indole derivatives
03/20/2003CA2459457A1 Benzothiazepine derivatives for the treatment of hyperlipidemia
03/20/2003CA2459445A1 Benzothiepine ileal bile acid transport inhibitors
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/19/2003WO2002024001A2 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
03/19/2003EP1293568A1 Novel protein and dna thereof
03/19/2003EP1293567A1 Ligand to gpr8 and dna thereof
03/19/2003EP1293510A1 Novel polypeptide and its dna
03/19/2003EP1293497A1 Process for the production of calcium pantothenate
03/19/2003EP1293211A1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292621A1 Compositions and methods for the endocytic presentation of immunosuppressive factors
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292595A1 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
03/19/2003EP1292585A1 Benzoxazepinones and their use as squalene synthase inhibitors
03/19/2003EP1292581A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
03/19/2003EP1292572A1 Propanolaminotetralines, preparation thereof and compositions containing same
03/19/2003EP1292570A1 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292564A2 Aminoalcohol derivatives
03/19/2003EP1292363A2 Carboxyalkylether-acat inhibitor combinations
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292301A1 Treatment and prevention of cardiac insulin resistance associated conditions
03/19/2003EP1292300A1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus
03/19/2003EP1292294A1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
03/19/2003EP1292293A1 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/19/2003EP1292284A2 Encapsulation of polynucleotides and drugs into targeted liposomes
03/19/2003EP1292213A1 A formula to manipulate blood glucose via the calculated ingestion of carbohydrate
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1196190B1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177195B1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV
03/19/2003EP1082344B1 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/19/2003EP1060162B1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
03/19/2003EP1056768B1 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
03/19/2003EP0934312B1 1,4-disubstituted piperazines
03/19/2003EP0796106B1 Protracted glp-1 compositions
03/19/2003EP0754035B1 Carotenoid agent for inhibiting the conversion of epithelial cells to melanomas
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof
03/19/2003CN1404483A New AZa-indolyl derivatives
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404479A Novel 1,3-dihydro-2H-indol-2-one derivatives their preparing method and the pharmceutical composition containing the same
03/19/2003CN1404478A Pyridinylimidazoles
03/19/2003CN1404476A Glycosidase inhibitors and preparation thereof
03/19/2003CN1404473A Substituted 8,8a-dihydro-3aH-indeno [1,2-D] thiazoles, a method for their production and their use as medicaments
03/19/2003CN1404472A Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404382A Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
03/19/2003CN1404364A Water containing soluble fiber
03/19/2003CN1403454A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403445A N-substituted nitrogen heterocyclic compound
03/19/2003CN1403154A Application of Hepcidin in pharmacy
03/19/2003CN1403146A Medicines composition for treating diabetes and its prepn
03/19/2003CN1403135A Medicine for treating diabetes and its complication
03/19/2003CN1403124A Cape jasmine medicine for dredging meridian and reducing blood fat and its prepn
03/19/2003CN1403120A Yusanxiao medicine for treating diabetes and its prepn
03/19/2003CN1403093A Oral vanadium replenishing agent with bimetallic oxide as carrier and its prepn and usage
03/19/2003CN1403092A Nutritive medicine for remitting or treating pregnant woman's vomiting
03/19/2003CN1103231C Chinese herbal medicines preparation of anti diabetes and complication and its preparing method
03/19/2003CA2422817A1 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
03/18/2003US6534663 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids
03/18/2003US6534652 Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534517 A polycyclic or heteropolycyclic compound containing amide or carboxy groups useful in the treatment and/or prevention of conditions mediated by nuclear receptors, in particular the peroxisome proliferator-activated receptor(PPAR)
03/18/2003US6534504 Increasing the quantity of meat or improving the quality of meat obtained from a livestock animal, comprising administering to the animal an effective amount of a compound represented by the following structural formula:
03/18/2003US6534496 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or
03/18/2003US6534487 Methods for suppressing appetite and enhancing exercise and recovery
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534110 Process for the preparation of materials with a high content of long chain polyunsaturated fatty acids
03/18/2003US6534088 Fibrate-statin combinations with reduced fed-fasted effects
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003CA2272705C Fused bicyclic pyrimidine derivatives
03/18/2003CA2269994C 7-hetero-bicyclo¬2.2.1|-heptanes
03/13/2003WO2003021262A1 Screening method
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020763A2 Soluble t cell receptor
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020749A2 Ncam binding compounds
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020711A1 Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin
1 ... 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 ... 1298